Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.124
H.R.124: Byron Nash Renal Medullary Carcinoma Awareness Act of 2021
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced Jan. 4, 2021
- Latest Major Action Feb. 2, 2021
- See the four similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
8 (4 Democrats, 4 Republicans)
Bill Version
- Introduced in House - Jan. 4, 2021
Bill Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2021 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Feb. 2, 2021 |
Referred to the Subcommittee on Health.
|
Jan. 4, 2021 |
Referred to the House Committee on Energy and Commerce.
|
Jan. 4, 2021 |
Introduced in the House by Al Green (D-Texas) |